Propofol Warning
After an FDA study found an increased risk of death among pediatric ICU patients who were sedated with Propofol, it issued a warning. The drug was not approved for use among pediatric ICU patients. The warning described the recent study and while noting that further study was merited, stressed that Propofol should not be used in the pediatric ICU setting.
The product warning label stresses that in the ICU Propofol should be administered only by persons skilled in the management of critically ill patients and trained in cardiovascular resuscitation and airway management and notes that patients who are sedated with Propofol in the ICU may suffer from Propofol Infusion Syndrome. Symptoms of Propofol Infusion Syndrome include blood imbalances, breakdown of muscle fiber, enlarged liver, heart and kidney failure.
It's also risky to abruptly stop a Propofol infusion. If patients are not properly weaned, they become agitated and may resist mechanical ventilation.
Propofol Recalls
There have been two recent recalls of Propofol because of problems with contamination that resulted in a warning letter from the FDA. At least 40 people developed fever, chills, and other flu-like symptoms. Propofol manufacturers Teva and Hospira recalled approximately 57,000 vials of Propofol. Later, Teva announced that it would permanently cease production of Propofol.
If you or a loved one has suffered harm as a result of the use of Propofol, seek legal help immediately to protect your rights. There is no fee and no other obligation, however, if you delay, you may lose your right to seek compensation for injuries caused by Propofol due to state-imposed time limits for filing a lawsuit.s
Check out the following articles for more information about Propofol, filing a Propofol lawsuit and finding a Propofol attorney.